ERIKIA RAMSEUR: Open Payments
NPI 1275315343 · MEDFORD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$100 in 5 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $89 · 2025 $100
Food & beverage: $100
| Company | Payments | Amount |
|---|---|---|
| Ascendis Pharma Endocrinology Inc | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
Products named: Yorvipath, REXULTI, TRINTELLIX.
Industry payments across OR — which companies pay providers there.
